Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marilyn Antoniak is active.

Publication


Featured researches published by Marilyn Antoniak.


Neuroepidemiology | 2003

Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population

Marilyn Antoniak; Maura Pugliatti; Richard Hubbard; John Britton; Stefano Sotgiu; A. Dessa Sadovnick; Irene M.L. Yee; Miguel A. Cumsille; Jorge A. Bevilacqua; Sarah Burdett; Lesley Stewart; Neil Pickering; Nino Khetsuriani; Eva S. Quiroz; Robert C. Holman; Larry J. Anderson; Rosalind Gait; Claire Maginnis; Sarah Lewis; Gustavo C. Román; Violeta Díaz; Torgeir Engstad; Ove Almkvist; Matti Viitanen; Egil Arnesen; Demosthenes B. Panagiotakos; Christina Chrysohoou; Christos Pitsavos; Alessandro Menotti; Anastasios Dontas

Objective: To describe the baseline characteristics of the participants in the Three-City (3C) Study, a study aiming to evaluate the risk of dementia and cognitive impairment attributable to vascular factors. Methods: Between 1999 and 2001, 9,693 persons aged 65 years and over, noninstitutionalized, were recruited from the electoral rolls of three French cities, i.e. Bordeaux, Dijon and Montpellier. Health-related data were collected during face-to-face interviews using standardized questionnaires. The baseline examination included cognitive testing and diagnosis of dementia, and assessment of vascular risk factors, including blood pressure measurements, ultrasound examination of the carotid arteries, and measurement of biological parameters (glycemia, total, high-density lipoprotein and low-density lipoprotein cholesterol, triglycerides, creatinemia); 3,442 magnetic resonance imaging (MRI) examinations were performed in subjects aged 65–79. Measurements of ultrasound, blood, and MRI parameters were centralized. Two follow-up examinations (at 2 and 4 years) were planned. Results: After exclusion of the participants who had subsequently refused the medical interview, the 3C Study sample consisted of 3,649 men (39.3%) and 5,645 women, mean age 74.4 years, with a relatively high level of education and income. Forty-two percent of the participants reported to be followed up for hypertension, about one third for hypercholesterolemia, and 8% for diabetes; 65% had elevated blood pressure measures (systolic blood pressure ≧140 or diastolic blood pressure ≧90). The proportion of Mini-Mental State Examination scores below 24 was 7% and dementia was diagnosed in 2.2% of the participants. Conclusion: Distribution of baseline characteristics of the 3C Study participants suggests that this study will provide a unique opportunity to estimate the risk of dementia attributable to vascular factors.


Clinical & Experimental Allergy | 2003

Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo‐controlled trial

Andrew W. Fogarty; Sarah Lewis; Sarah Scrivener; Marilyn Antoniak; Sarah J. Pacey; Mike Pringle; John Britton

Background Epidemiological studies suggest that higher intakes of dietary vitamin C and magnesium may be associated with a reduced risk of asthma.


BMC Health Services Research | 2006

Barriers and motivators to gaining access to smoking cessation services amongst deprived smokers--a qualitative study.

Elin Roddy; Marilyn Antoniak; John Britton; Andrew Molyneux; Sarah Lewis

BackgroundSmoking is strongly associated with disadvantage and is an important contributor to inequalities in health. Smoking cessation services have been implemented in the UK targeting disadvantaged smokers, but there is little evidence available on how to design services to attract this priority group.MethodsWe conducted focus groups with 39 smokers aged 21–75 from the most socio-economically deprived areas of Nottingham UK who had made an unsuccessful attempt to quit within the last year without using smoking cessation services, to identify specific barriers or motivators to gaining access to these services.ResultsBarriers to use of existing services related to fear of being judged, fear of failure, a perceived lack of knowledge about existing services, a perception that available interventions – particularly Nicotine Replacement Therapy – are expensive and ineffective, and negative media publicity about bupropion. Participants expressed a preference for a personalised, non-judgemental approach combining counselling with affordable, accessible and effective pharmacological therapies; convenient and flexible timing of service delivery, and the possibility of subsidised complementary therapies.ConclusionWe conclude that smokers from these deprived areas generally had low awareness of the services available to help them, and misconceptions about their availability and effectiveness. A more personalised approach to promoting services that are non-judgemental, and with free pharmacotherapy and flexible support may encourage more deprived smokers to quit smoking.


Thorax | 2003

Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients

Andrew Molyneux; Sion Lewis; U Leivers; A Anderton; Marilyn Antoniak; Anna Brackenridge; Fredrik Nilsson; Ann McNeill; Robert West; John Moxham; John Britton

Background: Guidelines recommend that smoking cessation interventions are offered in all clinical settings to all smokers willing to make a quit attempt. Since the effectiveness of routine provision of behavioural counselling and nicotine replacement therapy (NRT) to smokers admitted to hospital has not been established, a randomised controlled trial of these interventions given together compared with counselling alone or minimal intervention was performed in hospital inpatients. Methods: Medical and surgical inpatients who were current smokers at the time of admission were randomised to receive either usual care (no additional advice at admission), counselling alone (20 minute intervention with written materials), or NRT plus counselling (counselling intervention with a 6 week course of NRT). Continuous and point prevalence abstinence from smoking (validated by exhaled carbon monoxide <10 ppm) was measured at discharge from hospital and at 3 and 12 months, and self-reported reduction in cigarette consumption in smokers was assessed at 3 and 12 months. Results: 274 inpatient smokers were enrolled. Abstinence was higher in the NRT plus counselling group (n=91) than in the counselling alone (n=91) or usual care (n=92) groups. The difference between the groups was significant for validated point prevalence abstinence at discharge (55%, 43%, 37% respectively, p=0.045) and at 12 months (17%, 6%, 8%, p=0.03). The respective differences in continuous validated abstinence at 12 months were 11%, 4%, 8% (p=0.25). There was no significant difference between counselling alone and usual care, or in reduction in cigarette consumption between the treatment groups. Conclusions: NRT given with brief counselling to hospital inpatients is an effective routine smoking cessation intervention.


Thorax | 2003

Effects of volatile organic compounds, damp, and other environmental exposures in the home on wheezing illness in children

Andrea Venn; Marie Cooper; Marilyn Antoniak; C Laughlin; John Britton; Sarah Lewis

Background: The effects of indoor exposure to volatile organic compounds (VOCs), including formaldehyde, on respiratory health are not clearly understood. The aim of this study was to determine the independent effects of VOCs and other common environmental exposures in the home on the risk and severity of persistent wheezing illness in children. Methods: Total volatile organic compounds, formaldehyde, nitrogen dioxide, damp (on a four category scale of % wood moisture equivalent), and environmental tobacco smoke (from salivary cotinine) were measured objectively in the homes of 193 children with persistent wheezing illness and 223 controls aged 9–11 years in Nottingham, UK. Results: The risk of wheezing illness was significantly increased only in relation to damp (odds ratio (OR) per increasing category=1.32 (95% confidence interval (CI), 1.00 to 1.75)), and was unrelated to the other exposures measured. Among cases, formaldehyde and damp were associated with more frequent nocturnal symptoms (OR per increasing quartile and category, respectively, 1.45 (1.06 to 1.98) and 1.97 (1.10 to 3.53)), significantly more so in atopic cases, but there was no effect of total volatile organic compounds, nitrogen dioxide, or cotinine. Conclusions: Domestic volatile organic compounds are not a major determinant of risk or severity of childhood wheezing illness, though formaldehyde may increase symptom severity. Indoor damp increases both the risk and severity of childhood wheezing illness.


The Lancet | 2000

Risk of cryptogenic fibrosing alveolitis in metal workers

Richard Hubbard; Marie Cooper; Marilyn Antoniak; Andrea Venn; Sayeed Khan; Ian Johnston; Sarah Lewis; John Britton

We report increased proportional mortality from cryptogenic fibrosing alveolitis in the workforce of a major UK engineering company. Measures of metal exposure from unbiased historical occupational records showed that among employees who have worked with metal, the risk of death from or with cryptogenic fibrosing alveolitis increased in relation to the duration of metal-working.


Addiction | 2008

The effect of proactively identifying smokers and offering smoking cessation support in primary care populations: a cluster-randomized trial.

Rachael Murray; Tim Coleman; Marilyn Antoniak; Joanne Stocks; Alexia Fergus; John Britton; Sarah Lewis

AIMS To establish whether proactively identifying all smokers in primary care populations and offering smoking cessation support is effective in increasing long-term abstinence from smoking. DESIGN Cluster randomized controlled trial. SETTING Twenty-four general practices in Nottinghamshire, randomized by practice to active or control intervention. PARTICIPANTS All adult patients registered with the practices who returned a questionnaire confirming that they were current smokers (n = 6856). INTERVENTION Participants were offered smoking cessation support by letter and those interested in receiving it were contacted and referred into National Health Service (NHS) stop smoking services if required. MEASUREMENTS Validated abstinence from smoking, use of smoking cessation services and number of quit attempts in continuing smokers at 6 months. FINDINGS Smokers in the intervention group were more likely than controls to report that they had used local cessation services during the study period [16.6% and 8.9%, respectively, adjusted odds ratio (OR) 2.09, 95% confidence interval (CI) 1.57-2.78], and continuing smokers (in the intervention group) were more likely to have made a quit attempt in the last 6 months (37.4% and 33.3%, respectively, adjusted OR 1.23, 95% CI 1.01-1.51). Validated point prevalence abstinence from smoking at 6 months was higher in the intervention than the control groups (3.5% and 2.5%, respectively) but the difference was not statistically significant (adjusted OR controlling for covariates: 1.64, 95% CI 0.92-2.89). CONCLUSIONS Proactively identifying smokers who want to quit in primary care populations, and referring them to a cessation service, increased contacts with cessation services and the number of quit attempts. We were unable to detect a significant effect on long-term cessation rates, but the study was not powered to detect the kind of difference that might be expected.


Neurology | 2003

Occupational exposure to solvents and metals and Parkinson’s disease

L. McDonnell; Claire Maginnis; Sarah Lewis; Neil Pickering; Marilyn Antoniak; Richard Hubbard; Ian Lawson; John Britton

The etiology of PD is not clearly understood, but several genetic and environmental factors, including exposure to metals and solvents, have been implicated.1 In this study, we used pension fund and occupational records from a major UK engineering company to investigate whether occupational exposure to metals or solvents is associated with an increased risk of death from or with Parkinson’s disease. Cases were obtained by searching the Rolls-Royce PLC national pension fund archive of 20,256 death certificates from employees of five UK manufacturing locations who died between 1967 and 1997, identifying all with any mention of Parkinson’s disease on any part of the certificate. We then manually searched personnel archives at the location of work for the occupational record detailing the duration and title of all jobs held by each case. Controls were drawn from a previously ascertained random sample of 621 deaths (599 men) from the database for whom full occupational records had been traced and coded,2 excluding any who qualified as cases. We also excluded 199 controls …


American Journal of Respiratory and Critical Care Medicine | 2008

Does a Low Sodium Diet Improve Asthma Control? A Randomized Controlled Trial

Zara Pogson; Marilyn Antoniak; Sarah J. Pacey; Sarah Lewis; John Britton; Andrew W. Fogarty

RATIONALE Observational studies and initial randomized trials have indicated that a low sodium diet may improve asthma control. OBJECTIVES We tested the hypothesis that a low sodium diet would improve asthma control over a 6-week period. METHODS Participants with a physician diagnosis of asthma and measurable bronchial reactivity to methacholine entered a randomized double-blind placebo-controlled trial. All adopted a low sodium diet and were randomized to receive either 80 mmol/day of oral sodium supplements (normal sodium intake) or matched placebo (low sodium intake) for 6 weeks. The primary outcome was change in bronchial reactivity to methacholine; secondary outcomes were change in lung function, morning and evening peak expiratory flow, asthma symptoms score, daily bronchodilator use, Juniper Standardized Asthma Quality of Life Questionnaire score, and atopy. MEASUREMENTS AND MAIN RESULTS A total of 220 individuals entered the study, of whom 199 completed the protocol. In the low sodium-intake group, mean daily urinary sodium excretion decreased by 20 mmol (SD, 64 mmol) and in the normal-sodium-intake group increased by 28 mmol (SD, 74 mmol). There were no differences between the two groups in the primary or secondary outcome measures; the mean difference in bronchial reactivity between the low- and normal-intake groups was -0.03 doubling doses of methacholine (95% confidence interval, -0.60 to 0.53). CONCLUSIONS The use of a low sodium diet as an adjunctive therapy to normal treatment has no additional therapeutic benefit in adults with asthma and bronchial reactivity to methacholine.


Neuroepidemiology | 2003

Occupational Exposure to Metals and Solvents and the Risk of Motor Neuron Disease

Rosalind Gait; Claire Maginnis; Sarah Lewis; Neil Pickering; Marilyn Antoniak; Richard Hubbard; Ian Lawson; John Britton

Previous studies based on recalled occupational histories have implicated metal and solvent exposure in the etiology of motor neuron disease (MND). We have used death certificates held in pension fund archives and linked unbiased historical occupational records to investigate the effects of occupational exposure to metals or solvents on the risk of death from MND in 22 cases and 206 controls from 22,526 past employees of a major UK engineering company. We found no evidence of increased risk of death from MND in individuals who had worked with either metals (adjusted odds ratio = 0.88, 95% CI 0.35–2.22) or solvents (odds ratio = 1.12, 95% CI 0.45–2.78), and no relation between disease risk and either duration or intensity of exposure. We conclude that metal and solvent exposures are unlikely to be involved in the etiology of MND.

Collaboration


Dive into the Marilyn Antoniak's collaboration.

Top Co-Authors

Avatar

John Britton

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrea Venn

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarah J. Pacey

Nottingham City Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rosalind Gait

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

Zara Pogson

University of Nottingham

View shared research outputs
Researchain Logo
Decentralizing Knowledge